Salarius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SLRX and buy or sell other stocks, ETFs, and their options commission-free!About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.
CEODavid J. Arthur
CEODavid J. Arthur
Employees16
Employees16
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2014
Founded2014
Employees16
Employees16
SLRX Key Statistics
Market cap483.17M
Market cap483.17M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume586.79K
Average volume586.79K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.985
52 Week high$0.985
52 Week low$0.1511
52 Week low$0.1511
Stock Snapshot
With a market cap of 483.17M, Salarius Pharmaceuticals(SLRX) trades at $8.61.
During the trading day, Salarius Pharmaceuticals(SLRX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Salarius Pharmaceuticals(SLRX) stock has reached 0, versus its average volume of 586.79K.
The stock's 52-week range extends from a low of $0.15 to a high of $0.99.
The stock's 52-week range extends from a low of $0.15 to a high of $0.99.
People also own
Based on the portfolios of people who own SLRX. This list is generated using Robinhood data, and it’s not a recommendation.